schizandrin b has been researched along with Hypertriglyceridemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, ZS; Ko, KM; Pan, SY; Wang, XY; Xie, M; Yu, ZL; Zhang, Y; Zhao, J; Zhou, SF; Zhu, PL | 1 |
Dong, H; Fong, WF; Guo, BF; Han, YF; Ko, KM; Pan, SY; Yu, ZL; Zhang, Y | 1 |
Cao, HH; Chan, CL; Cheng, CY; Fong, WF; Hu, YM; Kwan, HY; Pan, SY; Tse, KW; Wu, YC; Yu, ZL | 1 |
Dong, H; Han, YF; Ko, KM; Li, WY; Pan, SY; Zhao, XY | 1 |
4 other study(ies) available for schizandrin b and Hypertriglyceridemia
Article | Year |
---|---|
Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice.
Topics: Adipocytes; Adipose Tissue; Animals; Antineoplastic Agents, Phytogenic; Apolipoprotein B-48; Cell Size; Cholesterol; Cholesterol, VLDL; Cyclooctanes; Fatty Acids, Nonesterified; Fatty Liver; Hepatocyte Growth Factor; Hepatomegaly; Hypertriglyceridemia; Lignans; Liver; Male; Mice; Mice, Inbred ICR; Mitochondria; Polycyclic Compounds; Schisandra; Triglycerides | 2017 |
Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate.
Topics: Animals; Cholesterol; Cyclooctanes; Disease Models, Animal; Dose-Response Relationship, Drug; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Lignans; Liver; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds; Schisandra; Triglycerides | 2011 |
Lipidomics identification of metabolic biomarkers in chemically induced hypertriglyceridemic mice.
Topics: Animals; Biomarkers; Calibration; Chromatography, Liquid; Cyclooctanes; Hypertriglyceridemia; Lignans; Lipids; Mice; Polycyclic Compounds; Principal Component Analysis; Reproducibility of Results; Tandem Mass Spectrometry; Triglycerides | 2013 |
A novel experimental model of acute hypertriglyceridemia induced by schisandrin B.
Topics: Animals; Cyclooctanes; Disease Models, Animal; Fenofibrate; Hypertriglyceridemia; Hypolipidemic Agents; Lignans; Lipids; Liver; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds | 2006 |